CD274 and non-small cell lung carcinoma: The combination of radiomics and PD-L1 detection in plasma extracellular vesicle (EV) had high sensitivity and specificity in identifying patients with NSCLC with non-response to ICIs and outperformed tissue PD-L1 (181), which could more effectively predict the efficacy and prognosis of patients with immunotherapy.